codexis.com - CDXS Company Long-Term Liabilities

Official company branding of Codexis Inc (CDXS)

Codexis, Inc. (CDXS) is betting on advanced protein engineering, utilizing the CodeEvolver system to optimize chemical reactions for eco-materials and medicine. The business relies on supplying biocatalysts to major B2B partners, reducing drug synthesis costs. The company's flawless image is confirmed by the trust of global pharma behemoths. The indicator stands at 0.08. The asset's price trajectory is illustrated in the chart below.

CDXS codexis.com: Company Long-Term Debts in the range 07/04/2022 - 10/28/2026
Mass-produced product of Codexis, Inc.

Codexis, Inc. maintains large-scale operations with a predictable cash flow. Long-term debt aggregates all credit obligations with maturities exceeding one year, reflecting the overall long-term credit burden. This metric allows for an assessment of financial stability and the business's ability to service loans using current earnings. An analysis of the company's long-term debt trend confirms that the capital structure aligns with standard stability norms.

Competing companies

Company Long-Term Debts Tempus Labs TEM|QGEN: Company Long-Term Debts|IONS: Company Long-Term Liabilities|Company Long-Term Debt RGEN|Avidity Corp (RNA) - Long-Term Debt|Company Long-Term Debts CRISPR Therapeutics AG (CRSP)|Company Long-Term Indebtedness genedx.com|Ultragenyx - Company Long-Term Debts|Long-Term Debt Beam Therapeutics Inc BEAM|SRPT - Company Long-Term Liabilities|Company Long-Term Indebtedness Twist Bioscience Corp TWST|Company Long-Term Debts TXG (10x Genomics, Inc.)|NTLA: Long-Term Debt Volume|Stoke Therapeutics, Inc. - Company Long-Term Debt|Long-Term Debt Volume BioLife Solutions Inc|WVE - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings Maze Therapeutics Corp|SION (Sionna Therapeutics Inc) - Company Long-Term Debts|Long-Term Debt Volume PRME (primemedicine.com)|TSHA - Company Long-Term Debt|Company Long-Term Indebtedness uniQure NV QURE|MGTX: Company Long-Term Debts|REGENXBIO Corp (RGNX) - Company Long-Term Liabilities|Solid Biosciences Inc. - Company Long-Term Liabilities|ocugen.com (OCGN) - Long-Term Debt Volume|Company Long-Term Debts PACB|Company Long-Term Liabilities Benitec Biopharma Inc|Company Long-Term Debts Design Pharma DSGN|Company Long-Term Indebtedness Rocket Corp RCKT|FDMT - Company Long-Term Liabilities|Lexeo Therapeutics Inc. - Company Long-Term Indebtedness|Company Long-Term Debt KRRO (Korro Bio, Inc)|EDIT - Long-Term Debt Volume|Company Long-Term Debts Silence Therapeutics Inc.|PRQR (ProQR Therapeutics) - Company Long-Term Indebtedness|Company Long-Term Debt Sangamo Therapeutics (SGMO)|Company Long-Term Indebtedness Nautilus Biotechnology Inc|Company Long-Term Debts MGX|Company Long-Term Debts Precision BioSciences Inc. (DTIL)|Generation Bio - Company Long-Term Debts|Boundless Bio Inc - Company Long-Term Liabilities|XCUR (Exicure Corp) - Company Long-Term Debt|IMNN - Long-Term Debt|Company Long-Term Debts phiopharma.com|Mustang Bio (MBIO) - Company Long-Term Indebtedness|Company Long-Term Debts RNAZ (TransCode Therapeutics Inc.)|Long-Term Debt Bionano (BNGO)|Company Long-Term Liabilities Applied DNA Sciences APDN|Company Long-Term Indebtedness bluebirdbio.com (BLUE)|Company Long-Term Debts IPA|Omega Therapeutics Inc - Long-Term Debt Volume|Company Long-Term Debt OMIC (Singular Genomics Systems Inc)|Regulus (RGLS) - Long-Term Debt Volume|Company Long-Term Liabilities Syros Pharmaceuticals SYRS|telesisbio.com (TBIO) - Company Long-Term Loans and Borrowings|TCON: Company Long-Term Debts|Long-Term Debt Volume UBX